MedWatch Safety Alerts
Exposure to lead can cause serious damage to the central nervous system, the kidneys, and the immune system.
Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events
FDA approves label changes after review of a five year safety study.
Potential risk of medication error or delay in therapy for patients that require high concentration potassium chloride.
UPDATED 09/16/2014. One AC/DC power adapter production lot added to recall. The casing on some AC/DC power adapters may become loose and separate, resulting in a potential for electric shock.
Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 mL by Hospira: Recall - Particulate Matter
Risk of injected particulate material which may result in local inflammation, phlebitis, and/or low-level allergic response.
Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): Drug Alert - Lack of Sterility Assurance
UPDATED 09/09/2014. FDA has issued a formal request to Downing Labs for the immediate recall of all lots of its purportedly sterile products currently on the market that are not expired.
Compromised sterility of a product may lead to risk for infection